Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Market Cap	1.08B
Revenue (ttm)	33.51M
Net Income (ttm)	-29.57M
Shares Out	119.80M
EPS (ttm)	-0.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	335,966
Average Volume	368,510
Open	n/a
Previous Close	8.60
Day's Range	8.70 - 9.10
52-Week Range	7.10 - 15.90
Beta	0.43
RSI	51.94
Earnings Date	Jan 29, 2026

About Central Pharmaceuticals

Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It offers tablets, capsules, liquids, and ointment. The company offers its products in various therapeutic areas, including gastrointestinal, anti-infective vitamins & minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, anti-diabetic oral rehydration salt, antihistamines, antifungal, vitamins, antihyperglycemic, anti-diabetic, analgesics and antipyretic NSAID; and skin diseases, such as fungal and...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Employees: 76
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: CENTRALPHL

Financial Performance

In 2025, Central Pharmaceuticals's revenue was 33.06 million, an increase of 11.68% compared to the previous year's 29.60 million. Losses were -21.98 million, -48.18% less than in 2024.